Results 231 to 240 of about 45,837 (320)

Stimulatory effect of immunoglobulins and Fc fragments on glucose oxidation and glucose transport by adipocytes.

, 1985
M.A. Khokher, Paresh Dandona
openalex   +1 more source

CD Molecules Nomenclature 2025: Antibody Validation and Expression Profiling of Immune System G Protein‐Coupled Receptors

European Journal of Immunology, Volume 55, Issue 12, December 2025.
HLDA Workshops were established 40 years ago to develop a standardized CD molecule nomenclature for leukocyte cell‐surface molecules by comparing monoclonal antibodies (mAbs) produced by different laboratories and companies. The HLDA11 Workshop focused on validating G‐protein‐coupled receptors (GPCRs) targeting mAbs and assessing cell‐type‐specific ...
Javier Fernández‐Calles, Daniela Kužílková, Fanny Hedin, Violeta Bakardjieva‐Mihaylova, Karolina Škvárová Kramarzová, Menno C. van Zelm, Antonio Cosma, Tomas Kalina, Pablo Engel, the Human Cell Differentiation Molecules (HCDM) organization   +9 more
wiley   +1 more source

Half-Life Extension of the IgG-Degrading Enzyme (IdeS) Using Fc-Fusion Technology. [PDF]

Eur J Immunol
Daventure V, Bou-Jaoudeh M, Hannachi E, Reyes-Ruiz A, Trecco A, Delignat S, Lacroix-Desmazes S, Deligne C.   +7 more
europepmc   +1 more source

Functional differences between CLL‐ and ALL‐derived CAR T cells in a 3D tumor microenvironment highlight CXCR4 and IL‐10 as potential modulatory targets

HemaSphere, Volume 9, Issue 12, December 2025.
Abstract Despite advances in targeted therapies, treatment of chronic lymphocytic leukemia (CLL) remains challenging, highlighting the urgent need for effective new therapeutic strategies. Although chimeric antigen receptor (CAR) T‐cell therapy dramatically improved outcomes in acute lymphoblastic leukemia (ALL), its efficacy in CLL is limited.
Janin Dingfelder, Michael Aigner, Jana Lindacher, Pascal Lukas, Cindy Flamann, Gina Nusser, Katharina Zimmermann, Axel Schambach, Frederik Graw, Simon Völkl, Heiko Bruns, Manuela Krumbholz, Martina Haibach, Jochen Wilke, Andreas Mackensen, Gloria Lutzny‐Geier   +15 more
wiley   +1 more source

Gene Profiling Analyses of Synovium Tissues in Korean Osteoarthritis Patients. [PDF]

In Vivo
Roh J, Jeon J, Jo S, Park G, Kang J, Moon SW, Kim W.   +6 more
europepmc   +1 more source

Pathways Contributing to Chemotherapy‐Induced Myotoxicity Are Attenuated by EPA + DHA in a Clinically Relevant Model of Colorectal Cancer

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 6, December 2025.
ABSTRACT Background Skeletal muscle loss is a well‐recognized consequence of cancer, and chemotherapy exacerbates myotoxicity through multiple mechanisms. Retaining muscle mass improves tumour response to therapies and tolerance to chemotherapy; hence, interventions to mitigate myotoxicity warrant investigations.
Peter O. Isesele, Bhumi J. Bhatt, Vickie E. Baracos, Sambasivarao Damaraju, Vera C. Mazurak   +4 more
wiley   +1 more source

Desensitization With Imlifidase: Overcoming Immunological Barriers in Kidney Transplantation. [PDF]

Kidney Med
Hernández-Velasco PJ, Gutiérrez Martínez E, Polanco Fernández N, González Monte ME, González-García C, Mancebo Sierra E, Andrés Belmonte A.   +6 more
europepmc   +1 more source

Targeted Therapy for Idiopathic Inflammatory Myopathy

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 6, December 2025.
ABSTRACT Background Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of autoimmune disorders characterized by chronic muscle inflammation and significant extramuscular involvement. A substantial proportion of patients exhibit refractory or relapsing disease despite conventional immunosuppressive therapies, necessitating the ...
Ruijie Wang, Wei Lin, Qibing Xie, Geng Yin   +3 more
wiley   +1 more source

[⁶⁴Cu]Cu-NOTA-EV-F(ab')₂ Enables Same-Day Immuno-PET Imaging of Nectin-4 in Triple-Negative Breast and Urothelial Bladder Cancers. [PDF]

J Nucl Med
Huang W, Li L, Chao F, Yang Q, Mixdorf JC, Engle JW, Hsu JC, Kang L, Cai W.   +8 more
europepmc   +1 more source

Engineered Low‐Endotoxin Bacterial Biomimetic Vesicles for Enhanced Oral Dual‐Antigen Subunit Vaccine Delivery

Journal of Extracellular Vesicles, Volume 14, Issue 12, December 2025.
A genetically engineered low‐endotoxin Salmonella choleraesuis biomimetic vesicle (CSS‐BBV), coated with COS, is utilized to enhance the oral delivery efficacy of subunit vaccines. The modular SpyCatcher/SpG design enables rapid dual‐antigen conjugation, providing a versatile platform for the development of infectious disease vaccines. ABSTRACT Subunit
Xuegang Shen, Shujie Wang, Kunying Qiu, Zeqing Liu, Xiaoxiao Tian, Fandan Meng, Yan‐Dong Tang, Haiwei Wang, Mingxia Sun, Xue‐Hui Cai, Tong‐Qing An, Yong‐Bo Yang   +11 more
wiley   +1 more source